130
Participants
Start Date
October 1, 2025
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Methylprednisolone (MP)
Methylprednisolone 1 mg/kg IV (diluted to 5 mL with saline) will be administered at induction of anesthesia. Neuromuscular blockade will be achieved with rocuronium. Reversal will be performed with sugammadex 2 mg/kg IV at the reappearance of the second twitch in train of four monitoring.
Dexamethasone
Dexamethasone 0.2 mg/kg IV (diluted to 5 mL with saline) will be administered at induction of anesthesia. Neuromuscular blockade will be achieved with rocuronium. Reversal will be performed with sugammadex 2 mg/kg IV at the reappearance of second twitch in train of four monitoring.
Konya City Hospital, Karatay
Konya City Hospital
OTHER